-
SOLUBLE GUANYLATE CYCLASE ACTIVATORS
申请人:Brockunier Linda L.
公开号:US20110218202A1
公开(公告)日:2011-09-08
Compounds of Formula I are capable of modulating the body's production of cyclic guanosine monophosphate (“cGMP”) and are generally suitable for the therapy and prophylaxis of diseases which are associated with a disturbed cGMP balance. The invention furthermore relates to processes for preparing compounds of the Formula I, to their use for the therapy and prophylaxis of the abovementioned diseases and for preparing pharmaceuticals for this purpose, and to pharmaceutical preparations which comprise compounds of the Formula I.
公式I的化合物能够调节体内环状鸟苷酸单磷酸(“cGMP”)的产生,一般适用于治疗和预防与cGMP平衡紊乱相关的疾病。此外,本发明还涉及制备公式I化合物的过程,以及它们用于治疗和预防上述疾病和制备药物的用途,以及包含公式I化合物的制药制剂。
-
Boldt,P. et al., Justus Liebigs Annalen der Chemie, 1968, vol. 718, p. 101 - 114
作者:Boldt,P. et al.
DOI:——
日期:——
-
Barbe, Werner; Beckhaus, Hans-Dieter; Ruechardt, Christoph, Chemische Berichte, 1983, vol. 116, # 3, p. 1058 - 1069
作者:Barbe, Werner、Beckhaus, Hans-Dieter、Ruechardt, Christoph
DOI:——
日期:——
-
Neumann, Norbert; Boldt, Peter, Chemische Berichte, 1984, vol. 117, # 5, p. 1935 - 1939
作者:Neumann, Norbert、Boldt, Peter
DOI:——
日期:——
-
NEUMANN, N.;BOLDT, P., CHEM. BER., 1984, 117, N 5, 1935-1939
作者:NEUMANN, N.、BOLDT, P.
DOI:——
日期:——